TRB Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TRB Wealth Management's PFE Position: Q3 2026 in Review
TRB Wealth Management reduced its Pfizer (PFE) stake by 47% in Q3 2026, selling an estimated $295K and leaving 12,293 shares worth $351K. The position accounts for 0.05% of the portfolio, ranked #190.
TRB Wealth Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. The position peaked at $767K in Q1 2026. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- TRB Wealth Management held 12,293 shares of Pfizer worth $351K as of Q3 2026.
- TRB Wealth Management sold 11,096 Pfizer shares in Q3 2026, an estimated $295K.
- Pfizer made up 0.05% of TRB Wealth Management's portfolio in Q3 2026, its #190 holding.
- TRB Wealth Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
- TRB Wealth Management's Pfizer position peaked at $767K in Q1 2026.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.